BHC
BHC
NYSE · Pharmaceuticals

Bausch Health Cos Inc

$4.80
+0.13 (+2.78%)
As of Jun 23, 9:59 PM ET ·
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 0 0%
Hold 5 56%
Sell 4 44%
Price Target
Analyst Price Target +2,062.1% upside
Low Target $65.08
Average Target $103.78
High Target $115.24
Current Price $4.80
Current
$4.80
Target
$103.78
$65.08 $103.78 avg $115.24
Scenario Analysis
Bear Case
$65.08
1,255.8%
Low target
Base Case
$103.78
+2,062.1%
Avg target
Bull Case
$115.24
+2,300.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.97
-59.9% from high
52-Week Low
$6.45
+-25.6% from low
50-Day SMA
$6.64
-27.7% vs SMA
200-Day SMA
$6.36
-24.5% vs SMA
RSI (14)
60.0
Neutral
Target vs 52W High
$103.78
+767.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%